Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, Efficacy and PK of OPC-67683 in Pulmonary Tuberculosis
NCT00401271Phase 2Completed
- Sponsor
- Otsuka Holdings
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of delamanid in pulmonary tuberculosis (TB), sponsored by Otsuka Holdings. Started Nov 2006; status: completed.
02
Drugs
delamanid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT00401271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00401271.